Literature DB >> 17363955

Soluble Fas ligand: is it a critical mediator of toxic epidermal necrolysis and Stevens-Johnson syndrome?

Junko Murata1, Riichiro Abe.   

Abstract

Although soluble Fas ligand (sFasL) is an important candidate in toxic epidermal necrolysis (TEN) and Stevens-Johnson syndrome (SJS), Stur and colleagues report that elevated sFasL has been detected in maculopapular rashes. In addition to sFasL, other factors, including predisposing genetic factors, should also be investigated to determine their precise pathogenesis in TEN and SJS.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17363955     DOI: 10.1038/sj.jid.5700693

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  3 in total

1.  Expression of soluble Fas and soluble FasL in human nucleus pulposus cells.

Authors:  Zhen Sun; Zhong-Yuan Wan; Zhi-Heng Liu; Yun-Shan Guo; Jun-Bin Yin; Chun-Guang Duan; Yang Gao; Tao Li; Hai-Qiang Wang; Zhuo-Jing Luo
Journal:  Int J Clin Exp Pathol       Date:  2013-07-15

2.  Curcumin in stevens-johnsons syndrome: culprit or bystander?

Authors:  Carla Irani; Fadi Haddad; Georges Maalouly; Rita Nemnoum
Journal:  World Allergy Organ J       Date:  2009-04       Impact factor: 4.084

Review 3.  Targeted therapy for intervertebral disc degeneration: inhibiting apoptosis is a promising treatment strategy.

Authors:  Xiao-Bo Zhang; Yi-Cun Hu; Peng Cheng; Hai-Yu Zhou; Xiang-Yi Chen; Ding Wu; Rui-Hao Zhang; De-Chen Yu; Xi-Dan Gao; Jin-Tao Shi; Kai Zhang; Shao-Long Li; Peng-Jie Song; Ke-Ping Wang
Journal:  Int J Med Sci       Date:  2021-05-27       Impact factor: 3.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.